POLISCOPE
Back to feed
NewsFOX 13 Tampa BayOctober 29, 2026Hillsborough County

Health and Human Services eases restrictions on compounding certain unapproved peptides

Photo: FOX 13 Tampa Bay

The Department of Health and Human Services announced a policy allowing licensed pharmacies and physicians to compound six unapproved peptides without facing Food and Drug Administration enforcement. The interim policy applies as long as compounders meet standards for ingredient quality, manufacturing, safety reporting, labeling, and patient-specific prescriptions.

Read the full story at FOX 13 Tampa Bay

Why It Matters

Patients gain broader access to specific unapproved through licensed compounders while federal regulators evaluate their potential inclusion in compounded medicines, altering enforcement risks for pharmacies and physicians.

Key Facts

  • Health and Human Services introduced an interim policy allowing licensed pharmacies and physicians to compound six unapproved peptides without facing Food and Drug Administration enforcement.
  • The six peptides covered by the policy include BPC-157, TB-500, epitalon, KPV, MOTS-c, and Semax.
  • Compounders must meet standards on ingredient quality, manufacturing requirements, safety reporting, labeling, and patient-specific prescriptions to avoid enforcement action.
  • HHS officials stated the policy aims to deter the use of research-use-only peptides from foreign manufacturers that pose safety risks while improving patient access.
  • Peptides have grown in popularity over the past year, supported by wellness influencers for uses ranging from anti-aging to muscle recovery and tissue repair.
  • Peptides are short chains of amino acids naturally produced by the body that regulate functions like hormone signaling, immune response, and tissue repair.

Who's Mentioned